MedTrace Logo

HEALthy Brain and Child Development Study - COVID-19 Supplement

NCT04713150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2026-04-06

No results posted yet for this study

Summary

The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic and will work to better support these families and children as they grow.

Conditions

  • Child Development
  • Prenatal Infection
  • Prenatal Stress
  • Covid19

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Charles A Nelson, PhD · Boston Children's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2023-09-14
Completion
2023-09-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04713150 on ClinicalTrials.gov